Home/Stocks/FNA

FNA

Paragon 28 Inc. Common Stock

$13.090+0.000 (0.000%)

Real-time Price

Price Chart

No chart data available

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$0.000

High

$0.000

Low

$0.000

Volume

N/A

Company Fundamentals

Trading Stats

Related News

Apr 9, 2025 · 04:34 PM

PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, BRDG, FNA on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Apr 4, 2025 · 04:43 PM

PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PLYA, QTRX, FNA on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Apr 3, 2025 · 10:00 PM

PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of FNA, BECN, QTRX, PLYA to Act Now

Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in...

Apr 1, 2025 · 02:54 PM

PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MHLD, TURN, FNA, PTMN on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mar 27, 2025 · 12:30 PM

PR Newswire

FINAL SHAREHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Paragon 28, Inc. (NYSE: FNA) Stockholder Buyout and Encourages Investors to Contact the Firm

Kaskela Law LLC announces that it is investigating the recently announced buyout of Paragon 28, Inc. ("Paragon") (NYSE: FNA) shareholders. Click here ...

BusinessWire

Mar 24, 2025 · 08:05 PM

Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference

Paragon 28, Inc. (NYSE:FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American College of Foot and Ankle Surgeons